Study of Daxdilimab (HZN-7734) in Participants With Moderate-to-Severe Primary Discoid Lupus Erythematosus
Clinical trial NCT05591222 · TERMINATED
Trial details
- NCT number
- NCT05591222
- Sponsor
- Amgen
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-29
- Primary completion
- 2025-05-08
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.